Advertisement

BPH/LUTS

Association of Angiotensin I Converting Enzyme Insertion/287 bp Deletion Polymorphisms and Proliferative Prostatic Diseases among Lebanese Men.

Feb 25, 2020

Angiotensin I converting enzyme (ACE) insertion (I) and 287 bp Alu repeat DNA fragment deletion (D) polymorphisms have been indicated in various cancers. Here, we investigated I/D polymorphisms in p...

Therapeutic Use of Pulsed Electromagnetic Field Therapy Reduces Prostate Volume and Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia.

Feb 25, 2020

Benign Prostatic Hyperplasia (BPH) etiology remains poorly understood, but chronic low-grade inflammation plays a role. Pulsed Electro Magnetic Field therapy (PEMF) (1-50Hz) are effective in reducing ...

Are oxidative stress and ischemia significant causes of bladder damage leading to lower urinary tract dysfunction? Report from the ICI-RS 2019.

Feb 18, 2020

Several studies indicate that pelvic ischemia and oxidative stress may play a significant role in lower urinary tract dysfunction (LUTD), including detrusor overactivity (DO)/overactive bladder (OAB) ...

Late onset hypogonadism (LOH): Prostate safety.

Feb 18, 2020

There have always been concerns regarding Testosterone Replacement Therapy (TRT) and prostate safety because of the central role of Testosterone (T) in prostate tissue. Even though there is a body of ...

Clinical Efficacy of Silodosin in Patients with Severe Lower Urinary Tract Symptoms Related to Benign Prostatic Obstruction: A Pooled Analysis of Phase 3 and 4 Trials.

Feb 18, 2020

We performed a post hoc analysis of data from phase 3 and 4 studies to evaluate the efficacy of silodosin 8mg in patients with severe lower urinary tract symptoms (LUTS) related to benign prostatic ob...

Postoperative Urinary Retention in Patients Undergoing Lung Resection: Incidence and Risk Factors.

Feb 18, 2020

The purpose of this study was to 1) determine the incidence of POUR in patients undergoing lung resection at our institution; 2) identify differences in potential risk factors between patients who did...

Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia.

Feb 18, 2020

To review the role of a persistent prostatic inflammatory status (PIS) in the development and progression of benign prostatic hyperplasia (BPH) associated with lower urinary tract symptoms (LUTS) and ...

Pathological characteristics of CD40/CD40L and NF-κB proteins related to inflammation in benign prostatic hyperplasia tissue: a retrospective study of 120 cases.

Jan 24, 2020

This paper aims to investigate the pathological characteristics of CD40/CD40L and NF-κB proteins related to inflammation in benign prostatic hyperplasia (BPH) tissue, as well as the outcomes of infla...

miR-27b expression in diagnosis and evaluation prognosis of prostate cancer.

Jan 24, 2020

The aim of study was to investigate the expression of microRNA-27b in different prostate tissues and its anti-tumor effects in prostate cancer.Measuring the expression of microRNA-27b, evaluating the ...

Associations of gene polymorphisms with the development and clinical progression of benign prostatic hyperplasia: a case-control study in northern Chinese population.

Jan 24, 2020

This study aims to explore the effect of gene polymorphisms of 5a-reduction enzyme (), steroidogenic cytochrome P-450 17alpha-hydroxylase (), aromatase cytochrome P450 family 19 () and vita-min D rece...

Readability of pelvic floor dysfunction questionnaires.

Jan 24, 2020

The National Institutes of Health and Center for Disease Control recommend the readability of self-administered patient questionnaires to be written at or below a sixth to eight grade reading level. T...

Efficacy and safety of 1470-nm Diode Laser Enucleation of the Prostate in Individuals with Benign Prostatic Hyperplasia Continuously Administered Oral Anticoagulants or Antiplatelet Drugs.

Jan 24, 2020

To evaluate the efficacy and safety of 1470-nm Diode Laser Enucleation of the Prostate (DiLEP) in patients with benign prostatic hyperplasia (BPH) continuously receiving oral anticoagulants or antipla...

SUBSPECIALTIES

Advertisement